GLP-1 weight-loss boom linked to surge in poison control calls (opens in new tab)

Covers 3 stories including National Poison Center Trends in GLP-1 Receptor Agonist Exposures Following FDA Approval for Weight Loss - Journal of Medical Toxicology

As the use of GLP-1 medications for weight loss surges, so do calls to U.S. poison control centers, according to a new study.

Read the original article

Sign in to keep reading the full article.